A Novel Fusion Protein Possessing Both Antiviral and pHSA-binding Activities Composed of Hepatitis B Virus Pre-S2 Peptide and Human α2a-interferon

The human α-interferon(IFNα) is a group of proteins possessing activity to render cells resistant to viral infection. It is one of the most promising and well documented recombinant proteins used in biotherapy. A product of recombinant human α2a-interferon(IFN-α2a) first developed in our laboratory has been put into clinical trials upon the approval of the China National Committee for Drug Administration. Data show that